IDEXX Laboratories Inc (IDXX)
477.80
-0.04
(-0.01%)
USD |
NASDAQ |
Apr 18, 16:00
477.80
0.00 (0.00%)
After-Hours: 19:38
IDEXX Laboratories Cash from Financing (TTM): -442.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -442.00M |
| September 30, 2023 | -456.87M |
| June 30, 2023 | -562.66M |
| March 31, 2023 | -503.54M |
| December 31, 2022 | -370.94M |
| September 30, 2022 | -420.04M |
| June 30, 2022 | -492.93M |
| March 31, 2022 | -581.24M |
| December 31, 2021 | -697.41M |
| September 30, 2021 | -531.20M |
| June 30, 2021 | -413.65M |
| March 31, 2021 | -394.97M |
| December 31, 2020 | -248.42M |
| September 30, 2020 | -323.20M |
| June 30, 2020 | -318.77M |
| March 31, 2020 | -266.73M |
| December 31, 2019 | -286.41M |
| September 30, 2019 | -329.83M |
| June 30, 2019 | -314.37M |
| March 31, 2019 | -275.59M |
| December 31, 2018 | -597.80M |
| September 30, 2018 | -558.05M |
| June 30, 2018 | -541.63M |
| March 31, 2018 | -534.32M |
| December 31, 2017 | -208.02M |
| Date | Value |
|---|---|
| September 30, 2017 | -207.21M |
| June 30, 2017 | -208.59M |
| March 31, 2017 | -218.32M |
| December 31, 2016 | -222.20M |
| September 30, 2016 | -209.54M |
| June 30, 2016 | -179.96M |
| March 31, 2016 | -140.35M |
| December 31, 2015 | -100.99M |
| September 30, 2015 | 5.945M |
| June 30, 2015 | -30.66M |
| March 31, 2015 | -51.68M |
| December 31, 2014 | -103.44M |
| September 30, 2014 | -178.83M |
| June 30, 2014 | -142.90M |
| March 31, 2014 | -119.66M |
| December 31, 2013 | -102.45M |
| September 30, 2013 | -119.24M |
| June 30, 2013 | -116.14M |
| March 31, 2013 | -116.53M |
| December 31, 2012 | -125.34M |
| September 30, 2012 | -71.49M |
| June 30, 2012 | -70.78M |
| March 31, 2012 | -80.77M |
| December 31, 2011 | -97.66M |
| September 30, 2011 | -113.16M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-697.41M
Minimum
Dec 2021
-248.42M
Maximum
Dec 2020
-418.69M
Average
-413.65M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| Haemonetics Corp | 100.06M |
| Align Technology Inc | -598.34M |
| Edwards Lifesciences Corp | -711.00M |
| ACADIA Pharmaceuticals Inc | 25.13M |